TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 120 resultados LastUpdate Última actualización 21/06/2021 [18:47:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Página1 de 5 nextPage   por página


TRANSLATING THERAPY PARAMETERS OF AN INSULIN THERAPY SYSTEM TO TRANSLATED THERAPY PARAMETERS FOR USE AT A DIFFERENT INSULIN THERAPY SYSTEM

NºPublicación: US2021178067A1 17/06/2021

Solicitante:

MEDTRONIC MINIMED INC [US]

Resumen de: US2021178067A1

Systems, storage media and computer-readable media are provided for translating one or more therapy parameters of a first insulin therapy system to one or more translated therapy parameters for use at a second insulin therapy system that is different than the first insulin therapy system. A therapy profile generated at the first insulin therapy system can be send to a translation service. The therapy profile includes one or more therapy parameters. At least one therapy parameter from the therapy profile can be translated into at least one translated therapy parameter that is mapped to and adapted for use by the second insulin therapy system. The at least one translated therapy parameter can then be sent to the second insulin therapy system for use at the second insulin therapy system.

traducir

ADJUSTING OPERATION OF A MEDICATION DELIVERY SYSTEM IN RESPONSE TO GESTURE-INDICATED ACTIVITY CHANGES

NºPublicación: US2021178068A1 17/06/2021

Solicitante:

MEDTRONIC MINIMED INC [US]

Resumen de: US2021178068A1

A system disclosed here includes an insulin infusion device, a gesture-based physical behavior detection system that generates gesture data for a user, and a controller that controls operation of the insulin infusion device. The controller performs adaptive training of at least one feature, function, setting, or model associated with the insulin infusion device, based at least in part on the sensor data. The controller processes activity-identifying data that indicates a current behavior pattern of the user, and that includes gesture data provided by the gesture-based physical behavior detection system. The controller determines, from the activity-identifying data, that the current behavior pattern differs from a currently implemented therapy behavior pattern of the user, and, in response to the determination, alters the adaptive training of the at least one feature, function, setting, or model.

traducir

MODULAR IMPLANTABLE MEDICAL DEVICE

NºPublicación: US2021177314A1 17/06/2021

Solicitante:

ROCHE DIABETES CARE INC [US]

Resumen de: US2021177314A1

An implantable medical device has an implantable power supply and an implantable medical unit. The implantable supply powers the device and it includes a hermetically sealed supply housing, a battery, and a supply power coupler that powers the implantable medical unit from the battery via a wireless coupling. The implantable medical device also has a hermetically sealed medical unit housing, and it includes a functional medical module including a continuous glucose meter module. In use, the implantable medical unit is releasably mechanically coupled to the implantable supply and a wireless coupling of a medical unit power coupler with a supply power coupler is made, thereby powering the medical unit from the battery of the implantable supply.

traducir

BLOOD GLUCOSE MEASUREMENT DEVICE

NºPublicación: US2021169383A1 10/06/2021

Solicitante:

SAMSUNG ELECTRONICS CO LTD [KR]

KR_20190084452_A

Resumen de: US2021169383A1

A blood glucose measurement device is disclosed. The present blood glucose measurement device comprises: a substrate; a first resonance sensor and a second resonance sensor arranged on the substrate; and a shield layer arranged below the second resonance sensor with respect to the direction from the second resonance sensor toward a subject.

traducir

TECHNIQUES AND DEVICES PROVIDING ADAPTIVITY AND PERSONALIZATION IN DIABETES TREATMENT

NºPublicación: US2021170104A1 10/06/2021

Solicitante:

INSULET CORP [US]

Resumen de: US2021170104A1

Disclosed are a device, system, methods and computer-readable medium products that provide an updated insulin-to-carbohydrate ratio and an updated total daily insulin. The described processes may be used for periodic updating of the insulin-to-carbohydrate ratio and the total daily insulin. The insulin-to-carbohydrate ratio and/or the total may be used in the calculation of new doses of insulin that a drug delivery device may be commanded to deliver to a user.

traducir

TRANSCUTANEOUS ANALYTE SENSOR

NºPublicación: US2021169380A1 10/06/2021

Solicitante:

DEXCOM INC [US]

US_2019015020_PA

Resumen de: US2021169380A1

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

traducir

SYSTEMS OF CENTRALIZED DATA EXCHANGE FOR MONITORING AND CONTROL OF BLOOD GLUCOSE

NºPublicación: US2021169409A1 10/06/2021

Solicitante:

UNIV VIRGINIA PATENT FOUNDATION [US]

US_2016331310_A1

Resumen de: US2021169409A1

A flexible system capable of utilizing data from different monitoring techniques and capable of providing assistance to patients with diabetes at several scalable levels, ranging from advice about long-term trends and prognosis to real-time automated closed-loop control (artificial pancreas). These scalable monitoring and treatment strategies are delivered by a unified system called the Diabetes Assistant (DiAs) platform. The system provides a foundation for implementation of various monitoring, advisory, and automated diabetes treatment algorithms or methods. The DiAs recommendations are tailored to the specifics of an individual patient, and to the patient risk assessment at any given moment. A central data exchange node or server collects patient data from individual DiAs devices and provides safety assurance, monitoring, telemedicine and database building for the DiAs system.

traducir

AN AIR BUBBLE DETECTION SYSTEM AND A DETECTION METHOD FOR INSULIN INFUSION SETS

NºPublicación: WO2021112804A1 10/06/2021

Solicitante:

CANKAYA NIHAT [TR]

Resumen de: WO2021112804A1

The invention relates to an air bubble detection device that detects air bubbles present in insulin passing through infusion sets used in the treatment of diabetes mellitus. It comprises a film sensor, an electronic circuit, a smartphone, and interface software that works on this smartphone and provides the coordination of all the equipment. The device can be adhered to the infusion sets of all types and sizes.

traducir

Systems and methods for patient monitoring using an HCP-specific device

NºPublicación: AU2021203005A1 10/06/2021

Solicitante:

DEXCOM INC [US]

US_2021142912_A1

Resumen de: AU2021203005A1

Systems and methods disclosed provide ways for Health Care Professionals (HCPs) to be involved in initial patient system set up so that the data received is truly transformative, such that the patient not just understands what all the various numbers mean but also how the data can be used. For example, in one implementation, a CGM device is configured for use by a HCP, and includes a housing and a circuit configured to receive a signal from a transmitter coupled to an indwelling glucose sensor. A calibration module converts the received signal into clinical units. A user interface is provided that is configured to display a measured glucose concentration in the clinical units. The user interface is further configured to receive input data about a patient level, where the input data about the patient level causes the device to operate in a mode appropriate to the patient level. WO 2018/125841 PCT/US2017/068327 LU>-U ~> I2 U -)

traducir

ACTIVITY TRACKING AND CLASSIFICATION FOR DIABETES MANAGEMENT SYSTEM, APPARATUS, AND METHOD

NºPublicación: US2021174971A1 10/06/2021

Solicitante:

UNIV CALIFORNIA [US]

WO_2020005822_PA

Resumen de: US2021174971A1

Activity tracking and classification for diabetes management is disclosed. In an example, an application operating on a user device or a server is configured to collect and synchronize lifelog data of a patient to atomic time intervals based on a time the lifelog data occurred or was recorded. The application or server is configured to segment the atomic intervals into daily activity intervals of first-level activities by determining if consecutive atomic intervals have a similar pattern of physical activity using at least a portion of the lifelog data. The application or server next selects a common daily activity model that corresponds to the patient and performs second-level activity recognition for each of the daily activity intervals using the selected common daily activity model. The application or server then generates, for display a personal chronical of the recognized second-level activities.

traducir

IMPEDIMETRIC/CAPACITIVE REUSABLE BLOOD GLUCOSE MEASUREMENT WITH MOLECULAR IMPRINTED POLYMERS

NºPublicación: WO2021112802A1 10/06/2021

Solicitante:

EGE UNIV [TR]

Resumen de: WO2021112802A1

The present invention relates to a sensor that can be used to measure blood glucose using molecular imprinting technology. The present invention generally relates to fast and precise, single frequency based impedimetric/capacitive electrochemical sensors in order to determine the amount of sugar (glucose, analyte) in liquid samples.

traducir

PSYCHOTHERAPY DEVICE FOR SENSING BRAIN WAVE SIGNAL, PSYCHOTHERAPY SYSTEM FOR DISPLAYING AND STORING BRAIN WAVE SIGNAL BY USING SAME, AND SYSTEM FOR MANAGING BRAIN WAVE SIGNAL THROUGH INTERMEDIATE MANAGER

NºPublicación: WO2021112270A1 10/06/2021

Solicitante:

HUMANLINE CO LTD [KR]

Resumen de: WO2021112270A1

The present invention relates to a psychotherapy device capable of measuring brain waves, comprising a body, a band, and a cushioning material. The body includes: a LED bar; a protection film; a brain wave measuring sensing means including one grounding electrode and a pair of brain wave measuring electrodes installed on both eye regions of the inner side of the body having the LED bar installed thereon so as to measure brain waves which are a type of bio-signal; and an USB interface for coupling same to a personal computer or smartphone. The psychotherapy device is connected to a personal computer or smartphone so as to operate, by using the personal computer or smartphone, according to a signal requesting measurement of the user's brain waves. The psychotherapy device transmits the sensed brain wave signal to the personal computer or smartphone, and performs electrocardiogram through an electrocardiogram sensor mounted on the user's ear. The psychotherapy device senses brain waves through the brain wave measuring sensing means, performs a brain stimulation operation, and transmits a brain wave signal to the personal computer or smartphone so that changes in the brain waves before/after use of the psychotherapy device are displayed in a three-dimensional waveform. The brain wave measuring sensing means provides a brain wave measurement signal, an oxygen saturation signal, a pulse rate, and a heart rate signal, which are related to the user, to the personal computer or smartp

traducir

TWO-LIQUID TYPE HEMOSTATIC COMPOSITION AND METHOD FOR MANUFACTURING THE SAME

NºPublicación: US2021162094A1 03/06/2021

Solicitante:

HYUNDAI BIOLAND CO LTD [KR]

Resumen de: US2021162094A1

Provided is a two-liquid type hemostatic composition that may be used adjunctively during a wide range of bleeding events and surgeries, and a method for preparing the same. The two-liquid type hemostatic composition does not contain blood products, comprises a first solution containing chitosan and a second solution containing a glucose or cellulose compound, may be easily applied in a liquid form to a wound or surgical bleeding site of the human body, and may help hemostasis and recovery by immediately forming a hydrogel at the bleeding area.

traducir

METHODS AND SYSTEMS FOR IMPROVING THE RELIABILITY OF ORTHOGONALLY REDUNDANT SENSORS

NºPublicación: US2021161439A1 03/06/2021

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2017150911_A1

Resumen de: US2021161439A1

Methods and systems for sensor calibration and sensor glucose (SG) fusion are used advantageously to improve the accuracy and reliability of orthogonally redundant glucose sensor devices, which may include optical and electrochemical glucose sensors. Calibration for both sensors may be achieved via fixed-offset and/or dynamic regression methodologies, depending, e.g., on sensor stability and Isig-Ratio pair correlation. For SG fusion, respective integrity checks may be performed for SG values from the optical and electrochemical sensors, and the SG values calibrated if the integrity checks are passed. Integrity checks may include checking for sensitivity loss, noise, and drift. If the integrity checks are failed, in-line sensor mapping between the electrochemical and optical sensors may be performed prior to calibration. The electrochemical and optical SG values may be weighted (as a function of the respective sensor's overall reliability index (RI)) and the weighted SGs combined to obtain a single, fused SG value.

traducir

Apparatus and Method for Optical Spectroscopy and Bioimpedance Spectroscopy using a Mobile Device Case to Gather Physiological Information

NºPublicación: US2021161423A1 03/06/2021

Solicitante:

VITA ANALYTICS INC [US]

WO_2018156624_PA

Resumen de: US2021161423A1

A mobile touchable system for user fitness and health monitoring is presented. The system is designed in one form as a mobile phone case and in another form as integrated in a mobile phone. It encompasses a series of measurement devices, including, but not limited to, arrays of electrodes for bio-impedance analysis, impedance tomography, and electrocardiographs, near-infrared spectroscopy for glucose level measurement, and heart rate monitoring. The touchable system performs incidental measurement in the background each time the user holds the mobile phone and hence enables long term health monitoring without user intervention. The touchable monitoring system further performs targeted spot measurements by following defined procedures. Spot measurement is enhanced through an extension measurement cable. Furthermore, an extension strap along with the mobile touchable system provides detailed activity tracking. The touchable system performs long term health monitoring, and provides early alerts for abnormal condition such as diabetes, dehydration, hypertension, cardiovascular anomalies, breast cancer and prostate cancer.

traducir

METHOD FOR CALIBRATING BLOOD GLUCOSE VALUE IN CONTINUOUS BLOOD GLUCOSE MEASUREMENT SYSTEM

NºPublicación: WO2021107335A1 03/06/2021

Solicitante:

I SENS INC [KR]

Resumen de: WO2021107335A1

The present invention relates to a method for calibrating a blood glucose value in a continuous blood glucose measurement system. More particularly, blood glucose values can be accurately calibrated according to a calibration mode by differently selecting calibration modes for calibrating blood glucose values on the basis of whether the difference between a blood glucose value measured by a continuous blood glucose measurement system and a reference blood glucose value measured by a separate blood glucose meter is outside a set range. In addition, the blood glucose value of a user can be accurately calibrated by activating, to be scrolled on an input window, only the ranges of the blood glucose value and a reference blood glucose value calculated on the basis of a preset critical range, or by forcibly or automatically calibrating the blood glucose value by a second calibration mode which uses multiple reference blood glucose values, when a reference blood glucose value outside the reference blood glucose value range is input.

traducir

ANALYTE SENSOR

NºPublicación: US2021161434A1 03/06/2021

Solicitante:

DEXCOM INC [US]

Resumen de: US2021161434A1

Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.

traducir

ARTIFICIAL NEURAL NETWORK BASED EARLY DIAGNOSIS OF DIABETES MELLITUS

NºPublicación: AU2021101904A4 03/06/2021

Solicitante:

BALACHANDER BHUVANESWARI [IN]
D MAHESWARI [IN]
HAQUE M AKIFUL [IN]
JAISWAL SUSHMA [IN]
KUMAR T CH ANIL [IN]
OHMSHANKAR S [IN]
RANJANI R [IN]
S PRATHIK [IN]
SHARMA DEEPANKAR [IN]
SRILALITHA SAPRAM [IN]

Resumen de: AU2021101904A4

ARTIFICIAL NEURAL NETWORK BASED EARLY DIAGNOSIS OF DIABETES MELLITUS Diabetes Mellitus is a type of common chronic disease, which if can be treated at an early stage can provide improved results. Disease prediction can be done at an early stage by using data mining techniques. In this invention, significant attributes are utilized for prediction of diabetes with characterization of different attributes with the relationship between them. The selection of significant attributes is based on various tools required for the process of clustering, prediction and the associated data mining rule for diabetes. Principal Component Analysis method used for selection of significant attributes. Apriori method is used for extraction of blood glucose level and body mass index of the patient as these two parameters are associated strongly with diabetes. Prediction of diabetes is done by implementing the Artificial Neural Network (ANN) method. Best accuracy is achieved by the proposed Artificial Neural Network (ANN) method for early detection of diabetes for assisting medical officers in making decisions related to treatment. cOmpret oft" Figure 1. Framework of Proposed ANN based Early Diabetes Detection Wn( 9Wk Wk p Wim X100oo X2 Output HL1 HL2 HL3 HL4 Hidden layers Figure 2. Layers involved in ANN Algorithmfor Diabetes Detection

traducir

Automated detection of a physical behavior event and corresponding adjustment of a medication dispensing system

NºPublicación: AU2019370301A1 03/06/2021

Solicitante:

MEDTRONIC MINIMED INC

CN_112889114_A

Resumen de: AU2019370301A1

An automated medication dispensing system provides for triggering a medication administration message when an inferred event is detected for which a medication administration message is to be sent. The event might be the start, the beginning, or an anticipation of a start, of an eating event, detected by an event detection module from gestures of a user from a set of sensor readings. The message can be a signal to medication dispensing apparatus, and/or a reminder message to the user, an ancillary message to a caregiver, health professional, or others. The medication administration message might comprise a signal to an input of an insulin management system or an input of a meal-aware artificial pancreas. The events might also include a drinking event, a smoking event, a personal hygiene event, and/or a medication related event.

traducir

ADAPTIVE ZONE MODEL PREDICTIVE CONTROL WITH A GLUCOSE AND VELOCITY DEPENDENT DYNAMIC COST FUNCTION FOR AN ARTIFICIAL PANCREAS

NºPublicación: US2021162127A1 03/06/2021

Solicitante:

HARVARD COLLEGE [US]

Resumen de: US2021162127A1

A system for the delivery of insulin to a patient is provided. The systems and methods disclose include an insulin delivery device configured to deliver insulin to a patient in response to control signals. The system also includes a controller programmed to receive the sensor glucose measurement signal from the glucose sensor. The sensor glucose measurement signal received indicates a concentration of the real time glucose concentration in a bloodstream. The controller is further configured to enact an impeding glycemia protocol based on a zone model predictive control (MPC) algorithm in response to the real time glucose concentration. The impeding glycemia protocol includes in determining a relationship between predicted glucose concentrations, a rate of change of the predicted glucose concentrations, and a set of control parameters that determine insulin doses above and below a patient-specific basal rate.

traducir

PATCH PUMP CARTRIDGE ATTACHMENT

NºPublicación: US2021162117A1 03/06/2021

Solicitante:

TANDEM DIABETES CARE INC [US]

US_2018264189_A1

Resumen de: US2021162117A1

A user-wearable patch pump system for delivery of insulin or other medicament can include a patch pump having a reusable drive unit and a replaceable and refillable cartridge. The cartridge can selectively attach to and be detached from the drive unit. The cartridge can initially be inserted onto the drive unit in a first orientation at an angle to the drive unit and then be rotated to align the cartridge with the drive unit and lock the cartridge in place on the drive unit to form the patch pump.

traducir

Analyte sensor

NºPublicación: US11020031B1 01/06/2021

Solicitante:

DEXCOM INC [US]

US_2021161434_A1

Resumen de: US11020031B1

Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.

traducir

System and method for data analytics and visualization

NºPublicación: AU2021202782A1 27/05/2021

Solicitante:

DEXCOM INC

US_2020074703_A1

Resumen de: AU2021202782A1

Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like. WO 2016/057343 PCT/US2015/053854 co C uJ uJ F- LU F- co U)) S co, LU, oi

traducir

Closed loop control of physiological glucose

NºPublicación: AU2021202523A1 27/05/2021

Solicitante:

LILLY CO ELI

JP_2020518340_A

Resumen de: AU2021202523A1

The present disclosure relates to a system to control glycemia in a patient, the system comprising a user interface for inputting patient data, the patient data including meal data; and a controller communicatively coupled to the user interface and configured to receive the patient data from the user interface, define a state vector and an associated model, the state vector comprising state variables including estimated values of insulin, carbohydrate, and physiological glucose in the patient, propagate the state vector, correct the propagated state vector by adding an amount of insulin to an insulin state variable, the amount of added insulin being based at least in part on the meal data, determine a dose request based, at least in part, on the corrected-state vector, andmtransmit the dose request.

traducir

Methods, devices, and systems for physiological parameter analysis

Nº publicación: AU2019368318A1 27/05/2021

Solicitante:

ABBOTT DIABETES CARE INC

CA_3117468_A1

Resumen de: AU2019368318A1

A method of calculating at least one physiological parameter using a reticulocyte production index (RPI) value including: measuring a plurality of first glucose levels over a first time period; measuring a first glycated hemoglobin (HbA1c) level corresponding to an end of the first time period; measuring the RPI value; calculating a red blood cell elimination constant (kage) based on the RPI value; and calculating the at least one physiological parameter selected from the group consisting of: a red blood cell glycation rate constant (kgly), a red blood cell generation rate constant (kgen), and an apparent glycation constant (K), based on (1) the plurality of first glucose levels, (2) the first HbA1c level, and (3) the kage. Further, one or more related analyses (e.g., personalized-target glucose range, personalized-target average glucose, cHbA1c, and the like) can be estimated and/or adjusted based on the at least one physiological parameter.

traducir

Página1 de 5 nextPage por página

punteroimgVolver